Nippon India Pharma Fund-IDCW Reinvestment

Mutual Fund Details – Invest Smart, Grow Wealth

Discover a variety of mutual funds tailored to your goals, from equity and debt to hybrid options. Track performance, compare funds, and get expert insights to make informed investment decisions. Grow your wealth with Motilal Oswal’s trusted mutual fund solutions.

Equity, Sectoral-Pharma, Principal at very high risk

1 Year Return 1.98% at 05 Feb 2026 11:22 AM

mf-nav

Fund Details

NAV 115.7359

Sub-Type Sectoral-Pharma

Rating 3

Min. SIP Amount ₹100.0

Fund Age(Year) 21.67

Fund Size(in Crores) 8264.7

Fund Performance

1 Month -3.06%

3 Month -4.02%

6 Month -4.04%

1 Year 1.98%

3 Year 22.07%

5 Year 14.27%

Know This Fund

As on 05 Feb 2026

Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.

Equity (97.37%) Market Cap Small Cap 29.77 Mid Cap 41.61 Large Cap 25.99 Top Sectors Healthcare 97.37 Top Holding Anthem Biosciences 0.83 Aurobindo Pharma 2.44 Apollo Hospitals Enterprise 5.53 Suraksha Diagnostic 1.27 Pfizer 1.92 Abbott India 2.61 Alkem Laboratories 2.16 Ipca Laboratories 2.05 Narayana Hrudayalaya 2.12 Syngene International 1.09 Astrazeneca Pharma India 0.68 Gland Pharma 1.67 Akums Drugs And Pharmaceuticals 0.83 Dr. Lal Pathlabs 2.19 Sanofi India 1.14 Lupin 7.36 Ajanta Pharma 3.21 Indoco Remedies 0.52 JB Chemicals 2.2 Biocon 1.06 Sun Pharmaceutical Industries 13.02 Fortis Healthcare 1.18 Medplus Health Services 3.54 Dr. Reddy's Laboratories 6.02 Mankind Pharma 2.01 Cipla 6.39 Sanofi Consumer Healthcare India 1.17 Thyrocare Technologies 2.37 Emcure Pharmaceuticals 1.23 Glaxosmithkline Pharma 2.73 Sai Life Sciences 2.81 Concord Biotech 0.18 Divi's Laboratories 6.58 Max Healthcare Institute 1.13 Vijaya Diagnostic Centre 3.71 Orchid Pharma 0.42

Debt & Others (2.63%) Sector Allocation Margin Money 0.01 Net Current Assets 0.98 Repo 1.64 Debt Credit Ratings Debt Category Others 2.63

Comparison with same funds

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -4.34% Ret 1Y -1.42% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -3.11% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Charges & Taxes Expense Ratio

Returns are taxed as per your Income Tax Slab.

Expense Ratio (Inclusive of GST): 1.82%

Exit Load 0%

Stamp Duty 0.005%

Fund Management

The various expenses, charges and taxes associated with your Mutual Fund

Divya Dutt Sharma

Education Bachelor of Commerce, MSC Banking & Finance.

Experience Prior to joining the Nippon AMC, he was associated with Bhramrishi Mission NGO, Equations LLC, V.K Pamecha and Associates.

Sailesh Raj Bhan

Education Mr. Bhan is an MBA (Finance) and CFA.

Experience Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst - Equity Research.

Lokesh Maru

Education Bachelor of Technology, CFA, FRM

Experience Prior to joining the Nippon AMC, he was associated with BlackRock Services India Private Ltd, CRISIL Ltd.

Riskometer

Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.

Principal at very high risk

AMC and Fund details

Rank (total sets) 3

Date of Incorporation 2004-06-05

Total AUM 2025-12-31

The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.

Latest News

news-by-category

VIEW MORE NEWS

Take Your Next Step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right